Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry.
Mar RiveiroAna Barreira DíazPaula EstebanRosa RotaCarmen Álvarez-NavascúesIndhira Pérez-MedranoBeatriz MateosElena GómezGema De-la-CruzCarlos FerreDiana HortaÁlvaro Díaz-GonzálezJavier AmpueroFernando Díaz-FontenlaMagdalena SalcedoJuan-Carlos Ruiz-CoboMaría Carlota LondoñoPublished in: Liver international : official journal of the International Association for the Study of the Liver (2024)
Rituximab is safe and effective in patients with refractory AIH and those treated due to concomitant autoimmune or haematological disorders.